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keep abreast of neighbouring fields. This book
contains some 1984 references and is as up to date
as hardbacks ever can be. It also contains the 1876
reference to the first recorded experimental
transplantation of a tumour, the canine
transmissible venereal tumour. Indeed it maintains
the high standard of the previous volumes.
'Cancer Metastasis' by Schirrmacher gives a clear
account of the experimental methods, from in vitro
transfection to various animal models, and a list of
scientific questions. Organ site predilection and
extravasation are discussed briefly but interestingly.
Angiogenesis and vascular distribution is given
more emphasis than lymphatic pathway spread.
Invasion by proteolysis is well discussed.
Immunological intervention in metastasis is
described clearly and somewhat optimistically. The
chapter is good on description but rather short on
criticism. It gives a good introduction to the subject
for new workers in the field.
Cohen's chapter about canine TVT is interesting
in showing that this undifferentiated tumour can be
transmitted by the transplantation of cells into
injured tissue even in immunocompetent allogeneic
dogs. It is believed that this transfer is unique in
nature. The lack of rejection is discussed but not
solved.
Rotter and Wolf discuss the tumour antigen p53.
This protein is present in greater quantity in
transformed than nontransformed cells, and is in
the nucleus of the former but in the cytoplasm of
the latter. Its role in cancer cells is discussed.
Schlom and nine co-authors describe the
approximately two dozen best-characterized mono-
clonal antibodies which are reactive with human
breast tumours. This is a timely progress report in a
fast-moving field; the number of these tumour
'fingerprints' is increasing. The problems of MAbs
for tumour therapy is sensibly discussed.
Folkman's chapter on tumour angiogenesis is a
model of clarity. His five pages on inhibitors of
angiogenesis, as a means of arresting tumour
growth, are interesting but inconclusive. The
marked variation of antiangiogenic activity of
different batches and makes of heparin is
mentioned.
Moelling describes the twenty-two oncogenes in
retroviruses that were known at the time of writing,
and possible mechanisms of transformation.
Szigeti describes the inhibition of migration of
polymorphonuclear granulocytes and macrophages
by LIF and MIF respectively as a test of cellular
immunity in tumours. A table summarising
apparently all of the 45 publications to date on the
application of this test to human breast cancer is
included. The nature and character of the
participating antigen(s) are not understood and
LMI studies cannot distinguish malignant and
benign pathological changes of the breast in a
reliable way. Applications to other solid tumours
are also reported thoroughly, with conflicting
results except in colorectal cancer where the LMI
assay, when combined with other tests, was found
to be promising.
This volume is well worthwhile both for reading
to remain up to date in general and as a source of
references for the particular topics.
J.F. Fowler
Molecular Medicine, Vol. 1. Edited by A.D.B.
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The editor of this new series, Alan Malcolm,
bravely claims in his introduction that 'future
improvements in health care are going to rely
heavily on our understanding of the molecular basis
of the (disease) process'. I do not disagree with this
statement but in the short-term the inability of the
molecular approach to describe the more complex
behaviour of whole organisms has prompted
numerous sterile critiques of the method and its
underlying reductionist philosophy. The success or
failure of Molecular Medicine will be judged by the
degree it demonstrates the real usefulness of
molecular analysis in a wide clinical setting. Is it a
useful area to cover in a series? Unequivocally yes,
as a forum for the two-way exchange of perspective
between clinician and molecular scientist. This is a
role that is not adequately filled by either the
specialist journals nor their occasional review
articles. Does it achieve these aims? The answer
here is that it has probably been pitched too
conservatively with too much emphasis on clinical
activity with no direct relationship to the topic of
Molecular Medicine as opposed to Medicine. This
is, in part, due to the initial choice of topics
covered and in part due to the particular interests
of some of the authors. I would add that all the
articles are of high standard, well produced and of
considerable interest.
The topics covered are fairly disparate and
should, in theory, be connected by the thread of
molecular analysis. This is certainly true of articles
on chromosome rearrangements and cancer,
collagen disorders and the use of NMR in clinical
imaging. Slightly less molecular are articles on
pulmonary emphysema, although much molecular
biology is applied to the a-1 antiprotease
inhibitor, and a very clear review of cholera and
related toxins. However, articles on alpha-
fetoprotein and the renin angiotensin system do not
really exploit molecular analysis and an extremely
readable, albeit bleak and depressing review of the152 BOOK REVIEWS
clinical aspects of AIDS does not touch on the
massive programme, mainly American, to use
recombinant DNA to dissect HTLV-III.
I have always been an enthusiastic supporter of
the molecular approach to clinical problems and
am sure that this series will have considerable
value. One hopes that the editor will be encouraged
to be more adventurous both in choice of authors
and in choice of subject. The choice of material for
review is large. What about slightly more clinically
speculative areas - growth factors in treatment of
disease or the role of oncogenes in cancer as well as
clinical areas still relatively unexplored by molecular
analysis - human embryonic development, for
example? These are all very fashionable areas at
present but they instil the huge excitement for the
future that is slightly missing in this volume.
P.F.R. Little